How to Prove MoCRA Compliance Without an FDA Certificate

The phrase “prove MoCRA compliance” sounds as if one official document should settle the issue. For cosmetic facility registration and product listing, that document does not exist. FDA confirmed on September 9, 2026 that it does not issue a registration certificate, listing certificate, verification letter, or exemption confirmation for cosmetics.

The defensible approach is narrower and more useful: show dated evidence for each statement you are making. A current portal record can support a facility-registration statement. A submission record can support a product-listing statement. A signed analysis can support an exemption position. None of those records, alone or together, should be described as FDA approval or proof of every obligation under MoCRA.

FDA’s new clarification makes this evidence-based method especially important for sellers answering marketplace and retailer requests.

Start by defining the claim

Before collecting documents, rewrite the request as a statement that can actually be supported. “Send your FDA certificate” is vague. The underlying question may be one of these:

• Is the manufacturing or processing facility registered, and is that registration active?
• Was this marketed cosmetic product listed with FDA?
• Does the seller maintain records supporting a claimed small-business exemption?
• Can the reseller trace the product to its supplier?
• Does the label identify the same entity and product shown in the records?

Ask the requester which item and identifier it needs when the portal prompt is ambiguous. A facility registration number, FDA Establishment Identifier (FEI), and Cosmetic Product Listing Number are not interchangeable labels for the same thing.

Build evidence in four layers

1. Scope and classification

Document the seller’s role, the entities involved, the physical manufacturing or processing locations, the responsible person, and the products in scope. The responsible person is generally the manufacturer, packer, or distributor whose name appears on the cosmetic label. A contract manufacturer and brand owner can therefore have different roles and records.

Confirm that the product is being evaluated under the right framework. FDA explains that intended use, including claims in online advertising, can make a product a drug or both a cosmetic and drug. An acne treatment, sunscreen, or antiperspirant should not be pushed through a cosmetic-only evidence path simply because it appears in a beauty category.

2. Facility-registration evidence

For each facility required to register, retain a dated record from the authenticated FDA system. FDA’s Cosmetics Direct page says the facility homepage displays registration status and renewal date. A useful capture shows the official source, legal establishment name, physical address, operation type, registration number, current status, and renewal date where available.

Facility registrations generally renew every two years, and required amendments are time-sensitive. “Last verified” and “next review” fields prevent a once-current screenshot from becoming permanent evidence.

3. Product-listing evidence

Maintain the latest first-party submission or portal record for each marketed cosmetic product, together with the corresponding label version. FDA’s registration and listing guidance says listings include the responsible person, product name, product category, ingredients, relevant facility information, and any previously assigned product listing number. Required listing updates are annual.

FDA also says the product listing number is not publicly disclosable. That makes controlled first-party records important: a third party may not be able to verify a listing by searching a public database. Record the number exactly, the associated product, the submission type, the submission date, and the source file. Do not publish confidential formulation information just to make the packet look comprehensive.

4. Supporting operational controls

Registration and listing are only part of MoCRA. FDA’s MoCRA overview also describes serious-adverse-event reporting, safety substantiation records, and other requirements and authorities. A marketplace may not request those records, but their existence is why a registration screenshot should not be called a “compliance certificate.”

At minimum, keep the marketplace evidence packet connected to—not confused with—your underlying label control, safety-substantiation file, and adverse-event process. The packet can point to a controlled record without disclosing sensitive material to a reviewer who did not request it.

Match the evidence to the business posture

For exemption claims, FDA defines a qualifying small business by average U.S. gross annual sales of cosmetic products for the previous three years below $1 million, adjusted for inflation, subject to exclusions for specified products. FDA does not issue exemption certificates. See our exemption letter guide before relying on that path.

Use precise, time-bounded language

A good evidence statement tells the reader what the record establishes and where it came from. For example:

“As of [date], the attached customer-provided Cosmetics Direct record displays [facility legal name], [physical address], registration number [number], registration status [status], and renewal date [date]. Exhibit 2 is the matching product label reviewed on the same date.”

For an independent review, add the reviewer’s company name and contact information and describe the scope. Do not say the reviewer “issued FDA certification.” Do not use FDA’s logo. Do not change an official screenshot to improve its appearance. If a name mismatch needs explanation, put the explanation on a separate page and attach evidence linking the names.

A repeatable six-step evidence workflow

1. Intake: save the exact marketplace or retailer request, date received, SKU, account, and deadline.
2. Classify: identify the seller role, regulatory category, facility, responsible person, and applicable evidence path.
3. Collect: retrieve first-party records, current labels, invoices, and exemption support as applicable.
4. Verify: check names, addresses, identifiers, status, renewal dates, submission types, product names, and document dates.
5. Map: build an evidence index that points each requested field to a document and page.
6. Archive: preserve the exact submitted version, record the outcome, assign the next review date, and keep sensitive backup material separate.

Use source strength in that order: authenticated first-party system records; original company and supply-chain records; then an explanatory or third-party summary. A polished summary cannot cure a wrong establishment, expired status, unsupported exemption, or mismatched label.

Turn scattered records into a controlled answer

The Syntera MoCRA Marketplace Compliance Evidence Pack ($39) gives you the practical components for this work: a facility-registration evidence checklist, Cosmetics Direct screenshot/status/renewal tracker, product-listing evidence tracker, FDA submission-confirmation log, marketplace-request tracker, portal-screenshot checklist, evidence index, last-verified controls, exemption self-attestation framework, and supporting-exemption-evidence checklist.

For ongoing ownership across multiple products, facilities, renewal dates, or marketplaces, move to the Syntera MoCRA Compliance Evidence & Renewal Control System ($99). It is the deeper operational layer for maintaining the evidence after the first request is closed. For the underlying agency position, share our FDA MoCRA certificate explainer.

Syntera provides independent documentation tools, not an FDA certificate, FDA verification, legal advice, or a guarantee of marketplace acceptance. FDA does not charge a fee to submit MoCRA facility registrations or cosmetic product listings.

Frequently asked questions